VistaGen Therapeutics Inc (VTGN) — Cash Flow-to-Debt Ratio
VistaGen Therapeutics Inc (VTGN) has a Cash Flow-to-Debt Ratio of -1.24x as of March 2026, meaning its operating cash flow of $-16.20 Million could theoretically repay -1% of its total liabilities ($13.04 Million) in one year. See VTGN free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
VistaGen Therapeutics Inc Cash Flow-to-Debt Ratio (2008–2026)
Historical debt coverage capacity for VistaGen Therapeutics Inc across 19 annual periods. For the full cash flow conversion analysis, see VTGN cash flow conversion.
Annual Cash Flow-to-Debt Ratio for VistaGen Therapeutics Inc (2008–2026)
Year-by-year debt coverage analysis for VistaGen Therapeutics Inc. Check VTGN cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -5.09x | $-66.44 Million | $13.04 Million | ▼ -68.8% |
| 2025 | -3.02x | $-42.10 Million | $13.95 Million | ▼ -9.5% |
| 2024 | -2.76x | $-25.81 Million | $9.37 Million | ▲ +50.1% |
| 2023 | -5.52x | $-49.72 Million | $9.01 Million | ▼ -21.1% |
| 2022 | -4.56x | $-45.26 Million | $9.93 Million | ▼ -515.5% |
| 2021 | -0.74x | $-12.07 Million | $16.30 Million | ▲ +45.9% |
| 2020 | -1.37x | $-15.76 Million | $11.50 Million | ▲ +34.6% |
| 2019 | -2.09x | $-14.53 Million | $6.94 Million | ▼ -0.8% |
| 2018 | -2.08x | $-9.06 Million | $4.36 Million | ▲ +11.5% |
| 2017 | -2.35x | $-7.26 Million | $3.10 Million | ▼ -93.5% |
| 2016 | -1.21x | $-4.81 Million | $3.97 Million | ▼ -811.1% |
| 2015 | -0.13x | $-2.77 Million | $20.81 Million | ▲ +18.3% |
| 2014 | -0.16x | $-2.13 Million | $13.06 Million | ▲ +36.9% |
| 2013 | -0.26x | $-3.46 Million | $13.44 Million | ▲ +56.3% |
| 2012 | -0.59x | $-3.57 Million | $6.05 Million | ▲ +72.6% |
| 2011 | -2.15x | $-6.88K | $3.20K | ▲ +85.8% |
| 2010 | -15.17x | $-22.76K | $1.50K | ▼ -182.3% |
| 2009 | -5.37x | $-14.43K | $2.69K | ▲ +73.2% |
| 2008 | -20.06x | $-4.81K | $240.00 | — |